Shanghai-based biotechnology company working in gene diagnosis, cellular immunotherapy and biopharmaceuticals, mainly for cancer.
Based in Shanghai, China, and established in 2012, Shanghai Topgen Pharmaceuticals focuses on gene diagnosis, molecular science, cellular immunotherapy and biopharmaceuticals, mainly for cancer treatment. It has branch sales offices in several Chinese provinces, more than 800 cooperating hospitals and more than 40 medical laboratories. The company reached a strategic cooperation with Illumina in January 2019 and was listed on the New Third Board in February 2016.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in